Gufic Biosciences Limited (GUFICBIO.NS)
INR 316.35
(2.03%)
INR 316.35
(2.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.53 Billion INR | -25.58% |
| 2022 | 2.06 Billion INR | 333.49% |
| 2021 | 477.26 Million INR | 24.78% |
| 2020 | 382.48 Million INR | 58.54% |
| 2019 | 241.24 Million INR | 113.28% |
| 2018 | 113.11 Million INR | 36.73% |
| 2017 | 82.72 Million INR | 22.09% |
| 2016 | 67.75 Million INR | -11.59% |
| 2015 | 76.64 Million INR | -33.38% |
| 2014 | 115.03 Million INR | -22.73% |
| 2013 | 148.88 Million INR | -19.16% |
| 2012 | 184.15 Million INR | 326.49% |
| 2011 | 43.18 Million INR | -79.18% |
| 2010 | 207.38 Million INR | 20.27% |
| 2009 | 172.43 Million INR | 15.96% |
| 2008 | 148.7 Million INR | -7.89% |
| 2007 | 161.44 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.79 Billion INR | 0.0% |
| 2023 FY | 1.53 Billion INR | -25.58% |
| 2023 Q4 | 1.53 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 2.06 Billion INR | 0.0% |
| 2022 FY | 2.06 Billion INR | 333.49% |
| 2022 Q2 | 1.11 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 477.26 Million INR | 24.78% |
| 2021 Q2 | 326.96 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 477.26 Million INR | 0.0% |
| 2020 Q2 | 439.59 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 382.48 Million INR | 58.54% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 382.48 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 241.24 Million INR | 113.28% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 261.7 Million INR | 0.0% |
| 2019 Q4 | 241.24 Million INR | 0.0% |
| 2018 Q4 | 113.11 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 102.76 Million INR | 0.0% |
| 2018 FY | 113.11 Million INR | 36.73% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 82.72 Million INR | 22.09% |
| 2017 Q4 | 82.72 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 119.96 Million INR | 0.0% |
| 2016 Q2 | 54.35 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 67.75 Million INR | -11.59% |
| 2016 Q4 | 67.75 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 76.64 Million INR | -33.38% |
| 2015 Q4 | 76.64 Million INR | 0.0% |
| 2015 Q2 | 81.92 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 115.18 Million INR | 0.0% |
| 2014 FY | 115.03 Million INR | -22.73% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 115.03 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 172.2 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 148.88 Million INR | 0.0% |
| 2013 FY | 148.88 Million INR | -19.16% |
| 2012 FY | 184.15 Million INR | 326.49% |
| 2012 Q4 | 184.15 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 75.9 Million INR | 0.0% |
| 2011 FY | 43.18 Million INR | -79.18% |
| 2011 Q4 | 43.18 Million INR | 0.0% |
| 2010 FY | 207.38 Million INR | 20.27% |
| 2009 FY | 172.43 Million INR | 15.96% |
| 2008 FY | 148.7 Million INR | -7.89% |
| 2007 FY | 161.44 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarti Drugs Limited | 2.75 Billion INR | 44.081% |
| Albert David Limited | 6.01 Million INR | -25492.271% |
| Alembic Limited | 73.9 Million INR | -1983.398% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | 15.299% |
| Hikal Limited | 4.22 Billion INR | 63.589% |
| Ind-Swift Limited | 10.09 Billion INR | 84.749% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | 382.22 Million INR | -302.812% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -144.852% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -1331.789% |
| Bajaj HealthCare Limited | 650.34 Million INR | -136.741% |
| Brooks Laboratories Limited | 3.56 Million INR | -43087.405% |
| Eris Lifesciences Limited | 6.54 Billion INR | 76.476% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -31.099% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -1937.357% |
| Wanbury Limited | 820 Million INR | -87.76% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -384807.75% |
| Alkem Laboratories Limited | 400 Million INR | -284.908% |
| FDC Limited | 2.46 Million INR | -62334.347% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -943.04% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -1279.276% |
| Innova Captab Limited | 2.1 Billion INR | 26.865% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ipca Laboratories Limited | 5.8 Billion INR | 73.473% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 95.139% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | 0.848% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -1052.928% |
| Medico Remedies Limited | 8.67 Million INR | -17654.048% |
| Morepen Laboratories Limited | 33.64 Million INR | -4476.787% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -9.732% |
| Orchid Pharma Limited | 1.2 Billion INR | -27.845% |
| Procter & Gamble Health Limited | 68.8 Million INR | -2137.836% |
| RPG Life Sciences Limited | -30.3 Million INR | 5181.29% |
| Sigachi Industries Limited | 265.79 Million INR | -479.249% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -11476.173% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -625.024% |
| Themis Medicare Limited | 267.74 Million INR | -475.047% |
| Vaishali Pharma Limited | 35.98 Million INR | -4178.773% |
| Venus Remedies Limited | 386.8 Million INR | -298.043% |
| Windlas Biotech Limited | 20.18 Million INR | -7529.49% |
| ZIM Laboratories Limited | 356 Million INR | -332.473% |
| Sakar Healthcare Limited | 549.55 Million INR | -180.162% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 92.788% |
| Divi's Laboratories Limited | 20 Million INR | -7598.155% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -5431.078% |
| Mankind Pharma Limited | 325.81 Million INR | -372.548% |
| Sequent Scientific Limited | 1.42 Billion INR | -7.878% |
| Laurus Labs Limited | 7.98 Billion INR | 80.712% |
| Neuland Laboratories Limited | 449.2 Million INR | -242.745% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -551.282% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -1.498% |
| Zydus Lifesciences Limited | 251 Million INR | -513.399% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -10922.559% |
| Wockhardt Limited | 8.91 Billion INR | 82.72% |
| Bal Pharma Limited | 363.82 Million INR | -323.18% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 74.297% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -332.575% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -16635.12% |
| Shilpa Medicare Limited | 5.6 Billion INR | 72.514% |
| Valiant Laboratories Limited | 750.89 Million INR | -105.038% |
| Ajanta Pharma Limited | 235.2 Million INR | -554.605% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -4674.973% |
| Granules India Limited | 689.71 Million INR | -123.229% |
| Medicamen Biotech Limited | 12.55 Million INR | -12163.09% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 126402.789% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.713% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 90.401% |
| NATCO Pharma Limited | 53 Million INR | -2804.964% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 16.096% |
| Strides Pharma Science Limited | 6.71 Billion INR | 77.072% |
| Indoco Remedies Limited | 3.51 Billion INR | 56.227% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -1344.307% |